Neurotechnology
Precision Neuroscience
Developer of the Layer 7 Cortical Interface, a thin-film, minimally invasive brain-computer interface that received FDA 510(k) clearance for intraoperative use of up to 30 days, a major extension from prior hours-long limits. Precision Neuroscience has raised roughly $183 million in total funding, partnered with UChicago Medicine researchers in April 2026 to advance BCI research, and is frequently cited as a contender to reach commercialization milestones ahead of Neuralink and Synchron given its less invasive surgical approach.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
2 sources · 61% avg. source confidence
- Fierce Biotech / MedTech Dive — FDA clears Precision Neuroscience's minimally invasive brain-computer interface implant66% source confidence
- We Will Cure / industry research — Precision Neuroscience partners with UChicago Medicine on BCI research56% source confidence
Dependency Map
What Precision Neuroscience depends on below, and who depends on Precision Neuroscience above — click any node to make it the new center, 5 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Precision Neuroscience's Timeline
A sourced, dated history of Precision Neuroscience's key moments — founding to present.
Jan 2021 · Founded
Precision Neuroscience was founded to develop a minimally invasive, thin-film cortical brain-computer interface.
Jan 2025 · FDA 510(k) clearance for Layer 7 Cortical Interface
Precision Neuroscience's Layer 7 Cortical Interface received FDA 510(k) clearance, extending permitted clinical use from hours to up to 30 days.